OneTest™ Premium – Multi-Cancer Test
OneTest™ Premium is a multi-cancer early detection blood test which reports risk for eight of the most common cancer types. These eight cancers represent 92.8%* of all cancers diagnosed in the US, according to the American Cancer Society. These cancers include lung, liver, colon, stomach, pancreatic, prostate (for men), breast and ovarian (for women).
OneTest™ Premium includes 11 biomarkers including the cancer biomarkers in OneTest™ (AFP, CEA, CA 19-9, CA 125, CA 15-3, PSA, CYFRA 21-1) and five additional biomarkers which measure inflammation, an important biological response associated with some types of cancer. These are HE4, ApoA1, B2-Microglobulin, CRP, and Prealbumin.
* Reference: American Cancer Society: “Cancer Statistics, 2023” in the American Cancer Society’s journal CA: A Cancer Journal for Clinicians.
OneTest™ Premium can help with early detection of lung, liver, pancreas, and other cancers that are not widely screened for in the United States.
Previously, multi-cancer blood tests to screen for common types of cancer was only available in other countries. In the US, cancer screening has been normally limited to colon, breast, cervical (for women), and prostate (for men). OneTest™ Premium is now available in the US to screen for multiple types of cancers with a single blood test for common cancers including lung, liver, pancreatic, ovarian, prostate, kidney and others.
Advantages of OneTest™ Premium vs Other Multi-Cancer Tests
In internal validation studies of real world data, OneTest™ Premium has been shown to offer 27% better sensitivity for
stage 1 (early stage) cancer compared to the leading multi-cancer test that utilizes circulating cell free DNA. Click here to see study results
We measure tumor antigens (not genes) which can help detect cancer now, not in the future
Many popular DNA testing companies today offer not only ancestry analysis, but also tests for inherited genetic abnormalities that pre-dispose the consumer to various diseases. Such tests have very limited value for early cancer detection since recent studies have confirmed that fewer than 5% of the genetic mutations that cause cancer are inherited. Instead, most cancer-causing mutations result from random DNA copying errors over time.
OneTest™ Premium is powered and validated by real-world data from asymptomatic individuals
Most biomarker-based cancer tests are developed and validated using stored laboratory blood samples from cancer patients. The purported accuracy of these tests usually drops considerably when they are later used in a real-world screening setting (i.e. Individuals without signs or symptoms of cancer).
Silent Progression vs. Early Insight: The OneTest™ Advantage
Cancer doesn’t announce itself. By the time symptoms appear, critical months of treatment opportunity have been lost forever.
THE TRADITIONAL PATH
Early Detection Advantage
Why Customers Chose OneTest™
“As someone in healthcare, I appreciate the scientific approach. The at-home testing made it incredibly convenient.”
“OneTest detected elevated markers early, leading to a Stage 1 diagnosis. Early detection made all the difference.”
“I do the test annually for peace of mind. The process is simple, and the detailed reports help me stay proactive about my health.”
“OneTest detected elevated markers early, leading to a Stage 1 diagnosis. Early detection made all the difference.”
Frequently Asked Questions
Is OneTest a replacement for regular cancer screenings?
OneTest is designed to complement, not replace, standard cancer screenings like mammograms and colonoscopies. It provides an additional layer of protection by detecting biomarkers that may indicate cancer before symptoms appear.
How accurate is the test?
OneTest is designed to complement, not replace, standard cancer screenings like mammograms and colonoscopies. It provides an additional layer of protection by detecting biomarkers that may indicate cancer before symptoms appear.
Is the at-home collection difficult?
OneTest is designed to complement, not replace, standard cancer screenings like mammograms and colonoscopies. It provides an additional layer of protection by detecting biomarkers that may indicate cancer before symptoms appear.
What happens if my test shows elevated risk?
OneTest is designed to complement, not replace, standard cancer screenings like mammograms and colonoscopies. It provides an additional layer of protection by detecting biomarkers that may indicate cancer before symptoms appear.
Early cancer detection through advanced biomarker testing and Al analysis.
© 2025 OneTest™. All rights reserved. OneTest is not intended to diagnose, treat, cure or prevent any disease.